VTVT
vTv Therapeutics Inc - Ordinary Shares - Class A

14,721
Mkt Cap
$150.44M
Volume
30,599.00
52W High
$44.00
52W Low
$14.00
PE Ratio
-10.76
VTVT Fundamentals
Price
$36.00
Prev Close
$35.97
Open
$35.05
50D MA
$35.66
Beta
0.88
Avg. Volume
30,140.83
EPS (Annual)
-$3.20
P/B
2.20
Rev/Employee
$0.00
$247.93
Loading...
Loading...
News
all
press releases
vTv Therapeutics Inc. (NASDAQ:VTVT) Receives Average Rating of "Moderate Buy" from Analysts
vTv Therapeutics Inc. (NASDAQ:VTVT - Get Free Report) has been given an average recommendation of "Moderate Buy" by the six brokerages that are currently covering the firm, MarketBeat Ratings...
MarketBeat·19h ago
News Placeholder
More News
News Placeholder
Wall Street Analysts Believe vTv Therapeutics (VTVT) Could Rally 39.86%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 39.9% in vTv Therapeutics (VTVT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks·5d ago
News Placeholder
Baker BROS. Advisors LP Has $3.46 Million Holdings in vTv Therapeutics Inc. $VTVT
Baker BROS. Advisors LP increased its stake in shares of vTv Therapeutics Inc. (NASDAQ:VTVT - Free Report) by 52.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and...
MarketBeat·7d ago
News Placeholder
Wall Street Zen Upgrades vTv Therapeutics (NASDAQ:VTVT) to "Hold"
Wall Street Zen upgraded shares of vTv Therapeutics from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·8d ago
News Placeholder
HC Wainwright Forecasts Higher Earnings for vTv Therapeutics
vTv Therapeutics Inc. (NASDAQ:VTVT - Free Report) - Investment analysts at HC Wainwright lifted their Q2 2026 earnings per share estimates for vTv Therapeutics in a report released on Wednesday...
MarketBeat·9d ago
News Placeholder
Research Analysts Set Expectations for VTVT Q1 Earnings
vTv Therapeutics Inc. (NASDAQ:VTVT - Free Report) - Equities research analysts at HC Wainwright boosted their Q1 2026 earnings per share estimates for shares of vTv Therapeutics in a report issued on...
MarketBeat·10d ago
News Placeholder
vTv Therapeutics (NASDAQ:VTVT) Share Price Crosses Below 50-Day Moving Average - Should You Sell?
vTv Therapeutics (NASDAQ:VTVT) Share Price Crosses Below 50 Day Moving Average - Time to Sell...
MarketBeat·10d ago
News Placeholder
vTv Therapeutics (VTVT) Projected to Post Earnings on Thursday
vTv Therapeutics (NASDAQ:VTVT) will be releasing earnings before the market opens on Thursday, March 19. (View Earnings Report at...
MarketBeat·10d ago
News Placeholder
vTv Therapeutics Inc. (NASDAQ:VTVT) Short Interest Up 61.2% in February
vTv Therapeutics Inc. (NASDAQ:VTVT - Get Free Report) saw a large increase in short interest during the month of February. As of February 13th, there was short interest totaling 50,829 shares, an...
MarketBeat·22d ago
News Placeholder
vTv Therapeutics Inc. (NASDAQ:VTVT) Receives Average Recommendation of "Moderate Buy" from Analysts
vTv Therapeutics Inc. (NASDAQ:VTVT - Get Free Report) has earned a consensus rating of "Moderate Buy" from the five brokerages that are covering the firm, Marketbeat Ratings reports. One analyst has...
MarketBeat·26d ago
<
1
2
...
>

Latest VTVT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.